about
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivoSevere thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.Specificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease.The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.Platelet antibody analysis by three different tests.A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.Biological properties of extracellular vesicles and their physiological functions.Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysateA robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells.Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.Function and activation state of platelets in vitro depend on apheresis modality.Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect.Donor selection and release criteria of cellular therapy products.Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice.Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.International Forum on GMP-grade human platelet lysate for cell propagation.International Forum on GMP-grade human platelet lysate for cell propagation: summary.Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations.Lesion-induced accumulation of platelets promotes survival of adult neural stem / progenitor cells.Iron depletion with a novel apheresis system in patients with hemochromatosis.Therapeutic red blood cell exchange in a child with sickle cell anaemia using the Spectra Optia® apheresis system.Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors.Thrombin generation before and after multicomponent blood collection.An alternative mini buffy coat preparation method for adult patients with extracorporeal photopheresis contraindications.Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells.
P50
Q27320392-64B2D59A-B4F4-4504-B597-E368623AB0FCQ33369106-F1F6C68C-C3D0-427A-9C01-0F090EF1885DQ33372491-93DD6D8F-7BD5-4D1B-A607-3BC90A599C37Q33383525-1560552D-57E2-40B4-9FFB-5E804A808DE0Q33398627-765D34E4-8572-4198-A97D-D635C4278553Q33415071-1691DA37-F936-405A-96CC-44D108CD1432Q34046864-C9A168BA-F8A4-4AF7-8787-F39ECC207357Q34876718-53228018-5BA7-4EC5-9F55-2C46F3E73132Q35611763-F70CA074-37E3-4354-BBB3-82460C123503Q36270533-8109A45A-AB3C-47BA-B5AC-EB30E98FD95BQ36337390-C8191EA4-918E-428C-8AAE-043B82E3320CQ36422761-8A826DA4-66ED-487C-AF31-8E5D2522C405Q37262399-CFA0AF02-2298-43FC-812B-51A1505D379DQ37723478-3BC49537-9D43-4CA8-BB28-2DA62038C30FQ38373823-B004CEC1-89E2-4963-835A-C28FC08D9777Q38444449-8E2B23DC-01EC-42D3-BD0C-B4D8D9E31AA5Q38631723-42385DC4-D4F0-438F-BA35-1CBF0371720BQ38758704-A8590528-E519-494C-B87F-373A108DE538Q39568332-C35AF00A-5AFC-4DF1-AC38-8922DA48B5A4Q40821352-02898ECF-6430-42DA-8A99-D5EA4D8116BEQ41034165-F3C86630-EC3A-4BAE-99B1-F234BD377760Q43025180-28053113-05DC-4F72-A0E8-24ACED789CEDQ43204525-A70E76D9-6716-449E-B7FD-83B432B5BF16Q43222889-ECF911F4-74A3-47C5-873D-A24A04FF3016Q43687671-0FD3299B-308A-4C42-B4A5-24D9935596CAQ44370728-260E449D-F49D-4C28-8FAA-982FFB2BFA1AQ45501605-D127F040-1EAD-4B48-9E70-DAD024FB6435Q46361829-1EB83A7C-49C7-4CA1-A710-63B0DA075910Q46488249-20860637-FC3F-4914-A717-F05807FD09A5Q47409155-61E409EB-69D3-4C55-850E-C0A943F5C372Q47565005-4F7BBE33-B3C2-4AA6-A2E2-23BDBDFD4E2DQ48030147-CECAF453-2CB4-4E18-AE15-036056CBD352Q48257595-E2912D8A-744F-453A-9BCF-5591E00537F5Q50456872-1D92AB46-9386-431C-9E45-54C0B365D9EAQ50476827-2B7B5717-3BE1-4F80-AFE5-E2F33880C5B4Q50513858-D4C36549-1890-40BC-B581-FCE27286E283Q50519734-FE14BE1F-2558-4F31-82E3-FC1BBC7E66AAQ50647997-591498A1-FBF5-46FA-A3D9-9D294EF1F971Q51471250-43A8EB39-B4F3-4877-A2F2-7DC790C6EF75Q52673002-EDE60ADA-E4FF-4A81-9534-361E6CB56F13
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katharina Schallmoser
@ast
Katharina Schallmoser
@en
Katharina Schallmoser
@es
Katharina Schallmoser
@nl
Katharina Schallmoser
@sl
type
label
Katharina Schallmoser
@ast
Katharina Schallmoser
@en
Katharina Schallmoser
@es
Katharina Schallmoser
@nl
Katharina Schallmoser
@sl
prefLabel
Katharina Schallmoser
@ast
Katharina Schallmoser
@en
Katharina Schallmoser
@es
Katharina Schallmoser
@nl
Katharina Schallmoser
@sl
P106
P21
P31
P496
0000-0002-7204-0058